Patent intelligence · US
US 12390512
Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae
Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae
Patent details — US 12390512
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 19, 2025
- Expiration
- Aug 14, 2045
- Applicant
- SHANGHAI REINOVAX BIOLOGICS CO., LTD
- Claims
- 20
- CPC classes
- A61K, A61K31/43, A61K38/47, A61K45/06
Quick answer
US 12390512 (Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae) is held by SHANGHAI REINOVAX BIOLOGICS CO., LTD. Status: granted. Granted Aug 19, 2025. Expires Aug 14, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SHANGHAI REINOVAX BIOLOGICS CO., LTD
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K31/43, A61K38/47, A61K45/06, A61P, A61P31/04
More from SHANGHAI REINOVAX BIOLOGICS CO., LTD
Related pharmaceutical patents in our USPTO index.
-
US 11033623
Magnetic stem cell therapy for lesions
granted -
US 10472381
Sialic acid derivatives
granted -
US 10265396
Magnetic extracellular matrix
granted -
US 9539228
Composition containing lysine as a nutritional supplement or treatment in the case of herpes
granted -
US 8309071
Foamy viral envelope genes
granted -
US 8293803
Retinoid compounds and their use
granted -
US 8268792
Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
granted
Frequently asked questions
What is US patent 12390512?
US 12390512 (Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae) is held by SHANGHAI REINOVAX BIOLOGICS CO., LTD. Status: granted. Granted Aug 19, 2025. Expires Aug 14, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12390512?
SHANGHAI REINOVAX BIOLOGICS CO., LTD is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 11 pharmaceutical patents for this assignee.
When does US 12390512 expire?
Our index shows an expiration date of Aug 14, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.